Compared to healthy individuals, COVID-19 patients show increased levels of inflammatory factors IL-6 and TNF-α due to the activation of Th17 cells, along with elevated expression of PD-L1 in CD8+ T cells and iTregs, accompanied by disturbances in tryptophan, amino acid, and glucose-lipid metabolism (165). The gene discussed is IL6; the disease is COVID-19.